retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports Retatrutide Research Peptide | COA

The honest recommendation: Start with Tirzepatide today

Treat blend-specific claims as inference from the component data, not proven blend outcomes

Maintaining a consistent weekly schedule is generally the safest approach unless a healthcare professional advises otherwise

Mounjaro targets type 2 diabetes

What we have is a plausible biological hypothesis (collagen peptide supplementation provides the amino acid substrates that bone matrix formation depends on, which may be relevant when those substrates are being depleted by rapid weight loss) supported by a strong positive RCT in a related population - and no direct evidence yet in the GLP-1 therapy population specifically

synergyvault.net #GLP1 #MetabolicHealth #PeptideResearch #SynergyVault #Biohacking #Longevity To view or add a comment, sign in 2,461 followers